Register Login

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Abstract

This research letter highlights a potential underrecognized safety signal of increased red blood cell transfusion associated with albumin therapy in critically ill patients, emphasizing the role of hemodilution and the importance of reporting transfusion exposure and long-term outcomes in future randomized trials involving albumin administration.

Downloads

pdf
Authors

Raffaele Mandarano Department of Anesthesia and Critical Care, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy ORCID

Stefano Romagnoli Department of Anesthesia and Critical Care, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; Department of Health Sciences (DSS), Section of Anesthesiology, Intensive Care and Pain Medicine, University of Florence, Florence, Italy

Mayurathan Balachandran Department of Intensive Care, Monash Health, Clayton, Victoria, Australia; The Victorian Heart Hospital, Clayton, Victoria, Australia ORCID

Yahya Shehabi The Victorian Heart Hospital, Clayton, Victoria, Australia; Monash Health School of Clinical Sciences, Clayton, Victoria, Australia; Clinical School of Medicine, University of New South Wales, Prince of Wales Hospital, Randwick, New South Wales, Australia

  • Abstract viewed - 605 times
  • pdf downloaded - 0 times